Comparison of idarubicin and daunorubicin regarding intracellular uptake, induction of apoptosis, and resistance

This publication has 31 references indexed in Scilit:

• Idarubicin DNA intercalation is reduced by MRP1 and not Pgp
  Leukemia, 1999
• A systematic collaborative overview of randomized trials comparing idarubicin with daunorubicin (or other anthracyclines) as induction therapy for acute myeloid leukaemia
  British Journal of Haematology, 1998
• Development of drug resistance is reduced with idarubicin relative to other anthracyclines
  Anti-Cancer Drugs, 1995
• DNA fragmentation as a consequence of cell cycle traverse in doxorubicin- and idarubicin-treated human lymphoma cells
  Annals of Hematology, 1994
• Flow cytometric study of idarubicin and daunorubicin accumulation and the effect of verapamil in leukemic cell lines and fresh cells from patients with acute non-lymphoblastic leukemia
  Leukemia Research, 1994
• BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER
  Annual Review of Biochemistry, 1993
• Anthracycline and anthraquinone anticancer agents: Current status and recent developments
  Pharmacology & Therapeutics, 1993
• ABC Transporters: From Microorganisms to Man
  Annual Review of Cell Biology, 1992
• Regulation of c-jun gene expression in HL-60 leukemia cells by 1-.beta.-D-arabinofuranosylcytosine. Potential involvement of a protein kinase C dependent mechanism
  Biochemistry, 1991
• The direct activation of human multidrug resistance gene (MDR1) by anticancer agents
  Biochemical and Biophysical Research Communications, 1989